Survival, complications and outcome in 282 patients operated for neurological deficit due to thoracic or lumbar spinal metastases.
We present survival, neurological function, and complications in a consecutive series of 282 patients operated for spinal metastases from January 1990 to December 2001. Our main surgical indication throughout this time period was neurological deficit rather than pain. Metastases from cancer of the prostate accounted for 40%, breast 15%, kidney 8%, and lung 7%. In 78% the level of decompression was thoracic and lumbar in 22%. Thirteen percent had a single metastases only, 64% had multiple skeletal metastases, and 23% had non-skeletal metastases also. Preoperatively 64% were non-walkers (Frankel A-C), 30% could walk with aids (Frankel D) and 8% had normal motor function (Frankel E). Posterior decompression and stabilization was applied in 212 patients, 47 had laminectomy only, and 23 had anterior decompressions and reconstruction. Complications were recorded at a level of 20%, and systemic complications were often associated with early death. The survival rate was 0.63 at 3 months, 0.47 at 6 months, 0.30 at 1 year, and 0.16 at 2 years. Twelve of 255 (5%) patients with motor deficits were worsened postoperatively, whereas 179 (70%) improved at least one Frankel grade. The ability to walk postoperatively was retained during follow-up in more than 80% of the patients. This study shows that important improvement of function can be gained by surgical treatment, but the complication rate was high and many patients died of their disease within the first months of surgery.
Jansson
Karl-Ake
KA
Oncology Service, Department of Orthopedics, Karolinska Hospital, 171 76 Stockholm, Sweden.
Bauer
Henrik C F
HC
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019299:Decompression, Surgical / Q000009:adverse effects / Q000401:mortality; D005260:Female; D006801:Humans; D008159:Lumbar Vertebrae / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D020335:Paraparesis / Q000401:mortality / Q000601:surgery*; D010264:Paraplegia / Q000401:mortality / Q000601:surgery*; D011446:Prospective Studies; D012086:Reoperation; D013117:Spinal Cord Compression / Q000601:surgery; D013125:Spinal Neoplasms / Q000401:mortality / Q000556:secondary* / Q000601:surgery; D013904:Thoracic Vertebrae / Q000601:surgery*; D016896:Treatment Outcome
J Clin Oncol. 1998 Apr;16(4):1613-24
9552073
J Bone Joint Surg Am. 1997 Apr;79(4):514-22
9111395
Spine (Phila Pa 1976). 1999 Sep 15;24(18):1943-51
10515021
Radiother Oncol. 1999 Aug;52(2):101-9
10577695
Radiother Oncol. 1999 Aug;52(2):111-21
10577696
Arch Orthop Trauma Surg. 1999;119(7-8):394-400
10613227
J Bone Joint Surg Br. 2000 Jul;82(5):673-8
10963164
Spine (Phila Pa 1976). 2001 Feb 1;26(3):298-306
11224867
Spine (Phila Pa 1976). 2002 Aug 15;27(16):1802-6
12195075
Med Oncol. 2003;20(3):203-9
14514969
J Bone Joint Surg Br. 2003 Sep;85(7):1045-50
14516044
Eur Spine J. 2003 Oct;12 Suppl 2:S202-13
14505120
Paraplegia. 1969 Nov;7(3):179-92
5360915
Spine (Phila Pa 1976). 1986 Apr;11(3):201-8
3715619
Clin Orthop Relat Res. 1988 Aug;(233):177-97
3402124
Spine (Phila Pa 1976). 1990 Nov;15(11):1110-3
1702559
Spine (Phila Pa 1976). 1993 Feb;18(2):257-63
8441942
Acta Orthop Scand. 1995 Apr;66(2):143-6
7740944
J Clin Oncol. 1995 Sep;13(9):2330-5
7666091
Cancer. 1998 Aug 15;83(4):726-31
9708937